Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 When to start antiretroviral therapy--ready when you are?

Literature DB >> 19339713

When to start antiretroviral therapy--ready when you are?

Paul E Sax, Lindsey R Baden.

Abstract

Mesh：

Substances：
Anti-Retroviral Agents

Year: 2009 PMID： 19339713 DOI： 10.1056/NEJMe0902713

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

1. Challenges in initiating antiretroviral therapy in 2010.

Authors: Cécile L Tremblay; Jean-Guy Baril; David Fletcher; Donald Kilby; Paul Macpherson; Stephen D Shafran; Mark W Tyndall
Journal: Can J Infect Dis Med Microbiol Date: 2010-08 Impact factor: 2.471

2. Early immunologic correlates of HIV protection can be identified from computational analysis of complex multivariate T-cell flow cytometry assays.

Authors: Nima Aghaeepour; Pratip K Chattopadhyay; Anuradha Ganesan; Kieran O'Neill; Habil Zare; Adrin Jalali; Holger H Hoos; Mario Roederer; Ryan R Brinkman
Journal: Bioinformatics Date: 2012-02-29 Impact factor: 6.937

3. Serum adenosine deaminase and total immunoglobulin G correlate with markers of immune activation and inversely with CD4 counts in asymptomatic, treatment-naive HIV infection.

Authors: Hayley Ipp; Annalise E Zemlin; Richard H Glashoff; Johan van Wyk; Naadira Vanker; Tim Reid; Linda-Gail Bekker
Journal: J Clin Immunol Date: 2012-11-16 Impact factor: 8.317

When to start antiretroviral therapy--ready when you are?

1. Challenges in initiating antiretroviral therapy in 2010.

2. Early immunologic correlates of HIV protection can be identified from computational analysis of complex multivariate T-cell flow cytometry assays.

3. Serum adenosine deaminase and total immunoglobulin G correlate with markers of immune activation and inversely with CD4 counts in asymptomatic, treatment-naive HIV infection.

Review 4. The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic.

5. Highly active antiretroviral treatment for the prevention of HIV transmission.

6. Investigation of the HIV-1 matrix interactome during virus replication.

7. Preventing HIV Transmission Among Partners of HIV-Positive Male Sex Workers in Mexico City: A Modeling Study.

8. Antiretroviral therapy needs: the effect of changing global guidelines.

9. The effects of setarud on the immunological status of HIV-positive patients: Efficacy of a novel multi-herbal drug.